LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that it will present a session on protein angiogenesis for the treatment of cardiovascular disease at the Euro-Biotech Forum, taking place in Paris from June 26-28, 2007. The presentation, titled “New Progress in Protein Angiogenesis Therapy for Cardiovascular Disease Patients,” will be given by Dr. Jack Jacobs, vice president and chief operating officer of CVBT.
